who cares about nasdaq, page-5

Agree Ibby, it's Ovarian cancer by the way.
But they are using it to treat other cancers that have Mucin-1 in them.

As for the sp I believe it to be t it's current place due to these factors:
- Australia is very resource and bank sector driven, we lack an understanding and appreciation for biotech (generally speaking). Hence why NASDAQ will open our investor base to a country that is more biotech aware than investors in Australia. Australian investors and fund managers are only opening their eyes up to biotech after Mesoblast blew the market apart last year and went on their radars.
- Springtree sp manipulation has kept a lid on where we should be at. With that said, we wouldn't be where we are today without them.
- Australian's generally have a short term mentality with biotech hence become impatient quickly, sell out and move on. Often missing big leaps and bounds as SP is driven by partnerships and clinical progress. Much different to resource stocks that produce a profit, which is what people here in Aus are used to.

Basically for everyone that says "damn, I wish I had have known about the dotcom boom", biotech is the next big thing.

We are transitioning from the information tech era and entering the biotech era.

The fact biotech is so misunderstood is why I chose to specialize in it.
The fact that the SP is low is great, means there is less risk and a bigger upside if the technology goes to market.

Don't worry about today's sp. If CVac makes it in 3 years time it will be $5+.

All these people worrying about the sp going from 21c to 26c to 22c and complaining about NASDAQ delay hurting the sp need to harden up.

In biotech it pays to be patient. Those who can sit on it will be rewarded.